These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29416202)

  • 1. Prevalence of Metabolic Syndrome in the Hospitalized Psychiatric Patients.
    Alswat KA; Alnemari AK; Alghamdi I; Almalki AA; Al-Thomali B; Mahfouz T
    Med Arch; 2017 Dec; 71(6):412-416. PubMed ID: 29416202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of metabolic syndrome and its components among patients with various psychiatric diagnoses and treatments: A cross-sectional study.
    Alosaimi FD; Abalhassan M; Alhaddad B; Alzain N; Fallata E; Alhabbad A; Alassiry MZ
    Gen Hosp Psychiatry; 2017; 45():62-69. PubMed ID: 28274341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of obesity, metabolic syndrome, diabetes and risk of cardiovascular disease in a psychiatric inpatient sample: results of the Metabolism in Psychiatry (MiP) Study.
    Barton BB; Zagler A; Engl K; Rihs L; Musil R
    Eur Arch Psychiatry Clin Neurosci; 2020 Aug; 270(5):597-609. PubMed ID: 31302731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Syndrome: Prevalence and Risk Factors among Adolescent Female Intermediate and Secondary Students in Saudi Arabia.
    Alowfi A; Binladen S; Irqsous S; Khashoggi A; Khan MA; Calacattawi R
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33671739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of different waist circumference cut-off values in predicting metabolic syndrome prevalence and risk factors in adults in China.
    Zhou HC; Lai YX; Shan ZY; Jia WP; Yang WY; Lu JM; Weng JP; Ji LN; Liu J; Tian HM; Ji QH; Zhu DL; Chen L; Guo XH; Zhao ZG; Li Q; Zhou ZG; Ge JP; Shan GL
    Biomed Environ Sci; 2014 May; 27(5):325-34. PubMed ID: 24827713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Treatment with Olanzapine in Hospital Conditions: Prevalence and Predictors of the Metabolic Syndrome.
    Popović I; Ravanić D; Janković S; Milovanović D; Folić M; Stanojević A; Nenadović M; Ilić M
    Srp Arh Celok Lek; 2015; 143(11-12):712-8. PubMed ID: 26946767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial.
    Gardner-Sood P; Lally J; Smith S; Atakan Z; Ismail K; Greenwood KE; Keen A; O'Brien C; Onagbesan O; Fung C; Papanastasiou E; Eberhard J; Patel A; Ohlsen R; Stahl D; David A; Hopkins D; Murray RM; Gaughran F;
    Psychol Med; 2015; 45(12):2619-29. PubMed ID: 25961431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnitude of metabolic syndrome in Gondar town, Northwest Ethiopia: A community-based cross-sectional study.
    Abebe SM; Demisse AG; Alemu S; Abebe B; Mesfin N
    PLoS One; 2021; 16(10):e0257306. PubMed ID: 34618823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of the metabolic syndrome in patients with carotid disease according to NHLBI/AHA and IDF criteria: a cross-sectional study.
    Maksimovic MZ; Vlajinac HD; Radak DJ; Marinkovic JM; Jorga JB
    BMC Cardiovasc Disord; 2012 Jan; 12():2. PubMed ID: 22292476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Syndrome in South African Patients with Severe Mental Illness: Prevalence and Associated Risk Factors.
    Saloojee S; Burns JK; Motala AA
    PLoS One; 2016; 11(2):e0149209. PubMed ID: 26882230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and cardiovascular risk among institutionalized patients with schizophrenia receiving long term tertiary care.
    Seow LS; Chong SA; Wang P; Shafie S; Ong HL; Subramaniam M
    Compr Psychiatry; 2017 Apr; 74():196-203. PubMed ID: 28214752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevelance of metabolic syndrome on the sample of paramedics.
    Rębak D; Suliga E; Grabowska U; Głuszek S
    Int J Occup Med Environ Health; 2018 Dec; 31(6):741–751. PubMed ID: 30572699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of metabolic syndrome components among the elderly using three different definitions: a cohort study in Finland.
    Saukkonen T; Jokelainen J; Timonen M; Cederberg H; Laakso M; Härkönen P; Keinänen-Kiukaanniemi S; Rajala U
    Scand J Prim Health Care; 2012 Mar; 30(1):29-34. PubMed ID: 22324547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordance of metabolic syndrome and abdominal obesity prevalence according to different criteria in Andean highlanders: A community-based study.
    Herrera-Enriquez K; Narvaez-Guerra O
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S359-S364. PubMed ID: 28284909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of premorbid metabolic syndrome in Spanish adult workers using IDF and ATPIII diagnostic criteria: relationship with cardiovascular risk factors.
    Tauler P; Bennasar-Veny M; Morales-Asencio JM; Lopez-Gonzalez AA; Vicente-Herrero T; De Pedro-Gomez J; Royo V; Pericas-Beltran J; Aguilo A
    PLoS One; 2014; 9(2):e89281. PubMed ID: 24586656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine use and sedentary lifestyle as determinants of metabolic syndrome in outpatients with schizophrenia.
    Eskelinen S; Sailas E; Joutsenniemi K; Holi M; Suvisaari J
    Nord J Psychiatry; 2015 Jul; 69(5):339-45. PubMed ID: 25981178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender and age-related differences in patients with the metabolic syndrome in a highly endogamous population.
    Bener A; Mohammad AG; Ismail AN; Zirie M; Abdullatef WK; Al-Hamaq AO
    Bosn J Basic Med Sci; 2010 Aug; 10(3):210-7. PubMed ID: 20846127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic syndrome among postmenopausal women in rural Canton: prevalence, associated factors, and the optimal obesity and atherogenic indices.
    Liang H; Chen X; Chen Q; Wang Y; Wu X; Li Y; Pan B; Liu H; Li M
    PLoS One; 2013; 8(9):e74121. PubMed ID: 24040183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of metabolic syndrome and its associated risk factors in an African-Caribbean population with severe mental illness.
    de Caluwé L; van Buitenen N; Gelan PJ; Crunelle CL; Thomas R; Casseres S; Matthys F; van Harten P; Cahn W
    Psychiatry Res; 2019 Nov; 281():112558. PubMed ID: 31546147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher prevalence of metabolic syndrome and related factors in patients with first-episode psychosis and schizophrenia: a cross-sectional study in Turkey.
    Sahpolat M; Ari M
    Nord J Psychiatry; 2021 Jan; 75(1):73-78. PubMed ID: 32886012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.